logo

For the Inventor, By the Inventor

Tokyo, Japan

Shigeru Kakuta

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The University of Tokyo, Tk Health Research, Co, Ltd.. Active years: 2015-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeru Kakuta. Retrieved from https://idiyas.com/inventor/shigeru-kakuta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal2 out of 1,356 
 
The University of Tokyo
 patents
silverMedal1 out of 1 
 
Tk Health Research, Co, Ltd.
 patent
where one patent can have more than one assignee

Years Active: 2015-2022

Loading Chart...
2 patents (USPTO):Explore Patents
1. 11331282 - Ophthalmic composition containing clathrated antioxidant substance, and use thereof (2022-05-17),
2. 9175054 - CTRP6 which can be used as therapeutic and prophylactic agent for autoimmune diseases (2015-11-03),

Title: Shigeru Kakuta: Innovator in Ophthalmic and Autoimmune Therapeutics

Introduction

Shigeru Kakuta is a notable inventor based in Tokyo, Japan. He has made significant contributions to the fields of ophthalmology and autoimmune disease treatment. With a total of two patents to his name, Kakuta's work focuses on innovative therapeutic compositions.

Latest Patents

Kakuta's latest patents include an ophthalmic composition containing a clathrated antioxidant substance. This invention provides a composition aimed at treating or preventing various ophthalmic diseases, including dry eye, conjunctivitis, and age-related macular degeneration. His second patent involves CTRP6, a therapeutic agent for autoimmune diseases, which suppresses the complement alternative pathway in mammals.

Career Highlights

Throughout his career, Shigeru Kakuta has worked with prestigious institutions such as the University of Tokyo and Tk Health Research Co., Ltd. His research has contributed to advancements in medical treatments and has garnered attention in the scientific community.

Collaborations

Kakuta has collaborated with notable colleagues, including Junwen Qin and Yuji Takahashi. Their combined expertise has furthered the development of innovative solutions in their respective fields.

Conclusion

Shigeru Kakuta's contributions to ophthalmic and autoimmune therapeutics highlight his role as a significant inventor. His patents reflect a commitment to improving health outcomes through innovative research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…